Form 4: Inspire Medical Systems Director Acquires Shares in Lieu of Cash Fees
SEC Form 4 Filing
Georgia Melenikiotou, a director at Inspire Medical Systems, acquired 56 shares of common stock on April 12, 2024, in lieu of cash fees.
Summary
- On April 12, 2024, Georgia Melenikiotou, a director of Inspire Medical Systems, acquired 56 shares of common stock.
- The shares were received in lieu of cash fees, as per the company's Non-Employee Director Compensation Policy.
- The price per share was $231.74.
- Following the transaction, Melenikiotou directly owns 1,386 shares of Inspire Medical Systems.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction, and the director taking shares instead of cash could be seen as a slightly positive signal.
Positives
- The director's decision to take shares in lieu of cash may signal confidence in the company's future performance.
Industry Context
This filing is a routine disclosure of a director's stock transaction, which is common in publicly traded companies. It provides transparency into the holdings and transactions of company insiders.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a small number of shares being transferred to a director as part of their compensation.
Key Dates
| Date | Description |
|---|---|
| 04/12/2024 | Date of transaction: Georgia Melenikiotou acquired 56 shares of common stock. |
| 04/16/2024 | Date of signature: The Form 4 was signed on this date. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.